Glecaprevir/pibrentasvir and sofosbuvir/ velpatasvir/voxilaprevir have been approved by the FDA- update coming soon.

In addition to updates for all relevant sections in response to the new approvals, the following new sections will be released soon:

• HCV in Children
• HCV in Pregnancy
• HCV Resistance Primer

FDA announcements:

• https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm570038.htm
• https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm567467.htm